These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 25693189

  • 1. Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.
    Bordi L, Lalle E, Caglioti C, Travaglini D, Lapa D, Marsella P, Quartu S, Kis Z, Arien KK, Huemer HP, Meschi S, Ippolito G, Di Caro A, Capobianchi MR, Castilletti C.
    PLoS One; 2015; 10(2):e0116816. PubMed ID: 25693189
    [Abstract] [Full Text] [Related]

  • 2. Type III interferon (IFN-lambda) antagonizes the antiviral activity of interferon-alpha in vitro.
    Bordi L, Lalle E, Lapa D, Caglioti C, Quartu S, Capobianchi MR, Castilletti C.
    J Biol Regul Homeost Agents; 2013; 27(4):1001-9. PubMed ID: 24382181
    [Abstract] [Full Text] [Related]

  • 3. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.
    Andersson I, Karlberg H, Mousavi-Jazi M, Martínez-Sobrido L, Weber F, Mirazimi A.
    J Med Virol; 2008 Aug; 80(8):1397-404. PubMed ID: 18551619
    [Abstract] [Full Text] [Related]

  • 4. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.
    Andersson I, Lundkvist A, Haller O, Mirazimi A.
    J Med Virol; 2006 Feb; 78(2):216-22. PubMed ID: 16372299
    [Abstract] [Full Text] [Related]

  • 5. Transcriptome profiling highlights regulated biological processes and type III interferon antiviral responses upon Crimean-Congo hemorrhagic fever virus infection.
    Mo Q, Feng K, Dai S, Wu Q, Zhang Z, Ali A, Deng F, Wang H, Ning YJ.
    Virol Sin; 2023 Feb; 38(1):34-46. PubMed ID: 36075566
    [Abstract] [Full Text] [Related]

  • 6. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
    Neogi U, Elaldi N, Appelberg S, Ambikan A, Kennedy E, Dowall S, Bagci BK, Gupta S, Rodriguez JE, Svensson-Akusjärvi S, Monteil V, Vegvari A, Benfeitas R, Banerjea A, Weber F, Hewson R, Mirazimi A.
    Elife; 2022 Apr 19; 11():. PubMed ID: 35437144
    [Abstract] [Full Text] [Related]

  • 7. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.
    Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, Mirazimi A.
    J Virol; 2004 Apr 19; 78(8):4323-9. PubMed ID: 15047845
    [Abstract] [Full Text] [Related]

  • 8. Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus.
    Welch SR, Scholte FEM, Flint M, Chatterjee P, Nichol ST, Bergeron É, Spiropoulou CF.
    Antiviral Res; 2017 Nov 19; 147():91-99. PubMed ID: 29024765
    [Abstract] [Full Text] [Related]

  • 9. Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.
    Karlberg H, Lindegren G, Mirazimi A.
    Open Virol J; 2010 Apr 22; 4():38-41. PubMed ID: 20517491
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.
    Ferraris O, Moroso M, Pernet O, Emonet S, Ferrier Rembert A, Paranhos-Baccalà G, Peyrefitte CN.
    Antiviral Res; 2015 Jun 22; 118():75-81. PubMed ID: 25796972
    [Abstract] [Full Text] [Related]

  • 11. Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.
    Scholte FEM, Hua BL, Spengler JR, Dzimianski JV, Coleman-McCray JD, Welch SR, McMullan LK, Nichol ST, Pegan SD, Spiropoulou CF, Bergeron É.
    mBio; 2019 Jul 23; 10(4):. PubMed ID: 31337717
    [Abstract] [Full Text] [Related]

  • 12. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW, Haddock E, Meade-White K, Williamson B, Hanley PW, Rosenke K, Komeno T, Furuta Y, Gowen BB, Feldmann H.
    Antiviral Res; 2018 Sep 23; 157():18-26. PubMed ID: 29936152
    [Abstract] [Full Text] [Related]

  • 13. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J, Devignot S, Åkerström S, Karlberg H, Wattrang E, Bereczky S, Mousavi-Jazi M, Risinger C, Lindegren G, Vernersson C, Paweska J, van Vuren PJ, Blixt O, Brun A, Weber F, Mirazimi A.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28250124
    [Abstract] [Full Text] [Related]

  • 14. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
    Lindquist ME, Zeng X, Altamura LA, Daye SP, Delp KL, Blancett C, Coffin KM, Koehler JW, Coyne S, Shoemaker CJ, Garrison AR, Golden JW.
    J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30111561
    [Abstract] [Full Text] [Related]

  • 15. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus.
    Paragas J, Whitehouse CA, Endy TP, Bray M.
    Antiviral Res; 2004 Apr 01; 62(1):21-5. PubMed ID: 15026198
    [Abstract] [Full Text] [Related]

  • 16. Antiviral effect of interferon lambda against West Nile virus.
    Ma D, Jiang D, Qing M, Weidner JM, Qu X, Guo H, Chang J, Gu B, Shi PY, Block TM, Guo JT.
    Antiviral Res; 2009 Jul 01; 83(1):53-60. PubMed ID: 19501257
    [Abstract] [Full Text] [Related]

  • 17. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.
    Espy N, Pérez-Sautu U, Ramírez de Arellano E, Negredo A, Wiley MR, Bavari S, Díaz Menendez M, Sánchez-Seco MP, Palacios G.
    J Infect Dis; 2018 May 25; 217(12):1952-1956. PubMed ID: 29584885
    [Abstract] [Full Text] [Related]

  • 18. Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus.
    Simon M, Falk KI, Lundkvist A, Mirazimi A.
    Virus Res; 2006 Sep 25; 120(1-2):184-90. PubMed ID: 16632039
    [Abstract] [Full Text] [Related]

  • 19. Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro.
    Földes F, Madai M, Papp H, Kemenesi G, Zana B, Geiger L, Gombos K, Somogyi B, Bock-Marquette I, Jakab F.
    Molecules; 2020 Dec 07; 25(23):. PubMed ID: 33297527
    [Abstract] [Full Text] [Related]

  • 20. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
    Spengler JR, Patel JR, Chakrabarti AK, Zivcec M, García-Sastre A, Spiropoulou CF, Bergeron É.
    J Virol; 2015 Oct 07; 89(20):10219-29. PubMed ID: 26223644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.